News

Psychedelics & the Path Forward: What the 2026 White House Executive Order Means For Clinicians and Patients

• May 31, 2026

Toward a Shared Language for Psychedelic-Assisted Psychotherapy

• May 27, 2026

We Are at the Inflection Point for Psychedelic Medicine

• May 18, 2026

Journey Clinical Welcomes Federal Action to Accelerate Access to Evidence-Based Psychedelic Treatments

• April 18, 2026

Journey Clinical Launched a Nationwide KAP Therapist Directory — Here’s Why It Matters

• April 16, 2026

Celebrating 2000+ Journey Clinical KAP Providers

• May 28, 2024

Journey Clinical and Compass Pathways Announce Research Collaboration for Psilocybin Treatment Delivery

• April 29, 2024

IPI Psychedelic Training: A Provider's Guide

• December 19, 2023

Celebrating 1000 Journey Clinical KAP Providers

• August 16, 2023

Journey Clinical at MAPS’ Psychedelic Science 2023 Conference

• July 6, 2023

SXSW Panel: The Business of Psychedelics featuring Myriam Barthes

• April 10, 2023

Our CEO’s Personal Journey with Psychedelics

• February 24, 2023

Journey Clinical Raises $8.5M Series A

• January 24, 2023

Horizons: Perspectives in Psychedelics Conference 2022 Recap

• October 28, 2022